Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis
Szente Fonseca et al.,
Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative..,
Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101906
Retrospective 717 patients in Brazil showing OR 1.17 [0.72-1.90] for ivermectin. This paper focuses on HCQ, event counts for ivermectin are not provided. With significant correlation between the variables used, including overlap in the prescription of multiple treatments that show efficacy alone, and limited data for the model size, the model used here may be inaccurate due to multicollinearity
[statisticsbyjim.com].
This study is excluded in the after exclusion results of meta
analysis:
result is likely affected by collinearity across treatments in the model.
|
risk of hospitalization, 13.9% higher, RR 1.14, p = 0.53, treatment 340, control 377, adjusted per study, odds ratio converted to relative risk, control prevalence approximated with overall prevalence, primary outcome.
|
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Szente Fonseca et al., 31 Oct 2020, retrospective, Brazil, peer-reviewed, mean age 50.6, 10 authors, average treatment delay 4.6 days, dosage 12mg days 1-2.
Abstract: Journal Pre-proof
Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens
in Brazil: Comparative Analysis
Silvia Nunes Szente Fonseca, Anastasio Queiroz de Sousa, Alexandre Giandoni
Wolkoff, Marcelo Sampaio Moreira, Bruno Castro Pinto, Christianne Fernandes
Valente Takeda, Eduardo Rebouças, Ana Paula Vasconcellos Abdon, Anderson L.A.
Nascimento, Harvey A. Risch
PII:
S1477-8939(20)30402-6
DOI:
https://doi.org/10.1016/j.tmaid.2020.101906
Reference:
TMAID 101906
To appear in:
Travel Medicine and Infectious Disease
Received Date: 14 August 2020
Revised Date:
10 September 2020
Accepted Date: 26 October 2020
Please cite this article as: Szente Fonseca SN, Queiroz de Sousa A, Wolkoff AG, Moreira MS, Pinto
BC, Valente Takeda CF, Rebouças E, Vasconcellos Abdon AP, Nascimento ALA, Risch HA, Risk of
Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative
Analysis, Travel Medicine and Infectious Disease, https://doi.org/10.1016/j.tmaid.2020.101906.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2020 Published by Elsevier Ltd.
Silvia Nunes Szente Fonseca: Conceptualization, Investigation, Resources, Data Curation, Writing Original Draft, Project administration
Anastasio Queiroz de Sousa: Investigation, Resources, Data Curation, Writing - Review & Editing
Alexandre Giandoni Wolkoff: Conceptualization, Investigation, Resources, Data Curation, Writing Review & Editing, Project administration
Marcelo Sampaio Moreira: Investigation, Resources, Data Curation, Writing - Review & Editing
Bruno Castro Pinto: Investigation, Resources, Data Curation, Writing - Review & Editing
of
Christianne Fernandes Valente Takeda: Investigation, Resources, Data Curation, Writing - Review &
Editing
Eduardo Rebouças: Investigation, Resources, Data Curation, Writing - Review & Editing
ro
Ana Paula Vasconcellos Abdon: Investigation, Resources, Data Curation, Writing - Review & Editing
-p
Anderson L. A. Nascimento: Investigation, Resources, Data Curation, Writing - Review & Editing
Jo
ur
na
lP
re
Harvey A. Risch: Conceptualization, Investigation, Data Curation, Formal Analysis, Writing - Review &
Editing
1
Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug
Regimens in Brazil: Comparative Analysis
Silvia Nunes Szente Fonseca 1, Anastasio Queiroz de Sousa 2, Alexandre Giandoni
Wolkoff 3, Marcelo Sampaio Moreira 3, Bruno Castro Pinto 3, Christianne Fernandes Valente
Takeda 3, Eduardo Rebouças 3, Ana Paula Vasconcellos Abdon 4, Anderson L. A.
Nascimento 3, Harvey A. Risch 5, 6
Hospital São Francisco, Ribeirão Preto, Brazil
2
Federal University of Ceará, Ceará , Brazil
3
Hapvida Saúde HMO, Fortaleza, Brazil
4
University of Fortaleza, Fortaleza, Brazil
5
Yale School of Public Health, New Haven, Connecticut USA
6
Correspondence to: Harvey A. Risch, M.D., Ph.D., Yale School of Public Health, 60
lP
re
-p
ro
of
1
na
College St., PO..
fonseca
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit
